Community based patient questionnaire survey to assess asthma control in 4 Indian cities

Trial description: According to the Global Initiative for Asthma (GINA) guidelines, the main goal of asthma treatment is to achieve and maintain clinical control. The Asthma Control Test (ACT) is a simple and validated tool to measure asthma control. A sub-analysis of data from Indian patients (from Mumbai, Delhi, Kolkata, Bengaluru) in Asthma Insights and Reality in Asia-Pacific (AIRIAP) 2006 survey, showed that 70% adults and 48% children had ‘not well-controlled asthma’ as indicated by an ACT score of 5-19. Over the last 6 years it appears that access to diagnostic tests, monitoring tools and better treatment options for asthma has increased in India. Therefore we expect that asthma control has improved in the last 6 years.This is a community based cross-sectional questionnaire survey of 550 asthma patients (ages 4 to 50 years) across 4 Indian cities, viz Mumbai, Delhi, Bengaluru and Kolkata. The aim of this survey will be to assess the current level of asthma control based upon the ACT score, the usage of diagnostic and monitoring tools for asthma, the usage of different classes of asthma medication, the level of healthcare utilization, the level of work productivity and activity impairment (WPAI), the relation between ACT score and WPAI outcomes, between ACT score and different classes of asthma medication, between ACT score and adherence to asthma medication. This survey will be conducted by Ipsos Healthcare using cluster sampling methodology.The results of this survey will help us to understand the extent to which these Indian cities have met GINA defined goals for asthma control (well controlled, total control) and to identify and focus on those areas that need additional resource to achieve guideline defined asthma control.